logo

For the Inventor, By the Inventor

Hachioji, Japan

Niro Inaba

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: National Institute of Advanced Industrial Science and Technology. Active years: 2007-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niro Inaba. Retrieved from https://idiyas.com/inventor/niro-inaba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 25.0


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Tsukuba, JP (2007)
  • Hachioji, JP (2008 - 2013)

Company Filing History:

goldMedal4 out of 1,765 
 
National Institute of Advanced Industrial Science and Technology
 patents

Years Active: 2007-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 8431365 - β1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same (2013-04-30),
2. 8227213 - β1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same (2012-07-24),
3. 7323324 - N-Acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor (2008-01-29),
4. 7223580 - N-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor (2007-05-29),

Title: Niro Inaba: Innovator in Cancer Research

Introduction

Niro Inaba is a prominent inventor based in Hachioji, Japan. He has made significant contributions to the field of cancer research, holding a total of 4 patents. His work focuses on the development of innovative methods and proteins that aid in the examination of canceration.

Latest Patents

One of Niro Inaba's latest patents involves the discovery of a β1,3-N-acetyl-D-galactosamine transferase protein, along with the nucleic acid encoding the same. This protein is characterized by its ability to transfer N-acetyl-D-galactosamine to N-acetyl-D-glucosamine with a β1,3 linkage. The invention also includes a method for examining canceration, utilizing a nucleic acid that hybridizes under stringent conditions to specific nucleotide sequences.

Career Highlights

Niro Inaba is affiliated with the National Institute of Advanced Industrial Science and Technology, where he conducts his research. His work has been instrumental in advancing the understanding of cancer mechanisms and developing potential diagnostic tools.

Collaborations

Niro Inaba has collaborated with notable colleagues, including Hisashi Narimatsu and Akira Togayachi. These partnerships have contributed to the success of his research endeavors.

Conclusion

Niro Inaba's innovative work in cancer research exemplifies the impact of scientific inquiry on health advancements. His patents and collaborations continue to pave the way for future discoveries in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…